Dottikon ES Holding (DESN) Stock Overview
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for DESN from our risk checks.
DESN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Dottikon ES Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 332.00 |
| 52 Week High | CHF 366.00 |
| 52 Week Low | CHF 151.00 |
| Beta | 1.01 |
| 1 Month Change | 2.63% |
| 3 Month Change | 10.67% |
| 1 Year Change | 53.35% |
| 3 Year Change | 32.80% |
| 5 Year Change | 90.80% |
| Change since IPO | 1,539.51% |
Recent News & Updates
If EPS Growth Is Important To You, Dottikon ES Holding (VTX:DESN) Presents An Opportunity
Oct 10
Dottikon ES Holding AG's (VTX:DESN) Business Is Trailing The Market But Its Shares Aren't
Sep 19Does Dottikon ES Holding (VTX:DESN) Have A Healthy Balance Sheet?
Aug 13Recent updates
If EPS Growth Is Important To You, Dottikon ES Holding (VTX:DESN) Presents An Opportunity
Oct 10Dottikon ES Holding AG's (VTX:DESN) Business Is Trailing The Market But Its Shares Aren't
Sep 19Does Dottikon ES Holding (VTX:DESN) Have A Healthy Balance Sheet?
Aug 13Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors
Jun 18Optimistic Investors Push Dottikon ES Holding AG (VTX:DESN) Shares Up 37% But Growth Is Lacking
May 29Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price
Feb 12These 4 Measures Indicate That Dottikon ES Holding (VTX:DESN) Is Using Debt Extensively
Dec 29Shareholder Returns
| DESN | CH Pharmaceuticals | CH Market | |
|---|---|---|---|
| 7D | 0.2% | 2.4% | 2.0% |
| 1Y | 53.3% | 32.2% | 13.2% |
Return vs Industry: DESN exceeded the Swiss Pharmaceuticals industry which returned 32.2% over the past year.
Return vs Market: DESN exceeded the Swiss Market which returned 13.2% over the past year.
Price Volatility
| DESN volatility | |
|---|---|
| DESN Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 4.1% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.8% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: DESN has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: DESN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | 875 | Markus Blocher | dottikon.com |
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries.
Dottikon ES Holding AG Fundamentals Summary
| DESN fundamental statistics | |
|---|---|
| Market cap | CHF 4.59b |
| Earnings (TTM) | CHF 120.97m |
| Revenue (TTM) | CHF 432.92m |
Is DESN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DESN income statement (TTM) | |
|---|---|
| Revenue | CHF 432.92m |
| Cost of Revenue | CHF 151.72m |
| Gross Profit | CHF 281.20m |
| Other Expenses | CHF 160.23m |
| Earnings | CHF 120.97m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
May 29, 2026
| Earnings per share (EPS) | 8.75 |
| Gross Margin | 64.96% |
| Net Profit Margin | 27.94% |
| Debt/Equity Ratio | 12.5% |
How did DESN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/22 03:59 |
| End of Day Share Price | 2025/12/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dottikon ES Holding AG is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Jelovcan | Zürcher Kantonalbank |